IP Library Granted Patent US 11,098,375
Granted Patent B2
US 11,098,375 · App. 14/380,666 · Granted Aug 24, 2021

Detection of Shiga toxin genes in bacteria

Inventor: Ejan Tyler (San Diego, CA)
Assignee: Gen-Probe Prodesse, Inc.
C12Q1/689C12Q2600/16
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,098,375
App. No.
14/380,666
Granted
Aug 24, 2021
Kind
B2
Abstract

The disclosed invention is related to methods, compositions and kits for targeting nucleic acid derived from Shiga toxin-producing bacteria such as E. coli . Compositions include amplification oligomers and/or detection probe oligomers. Kits and methods comprise at least one pair of amplification oligomers.

Claims (28)

1. A method for identifying a stx1 gene in a sample, the method comprising:

a) contacting the sample with a pair of amplification oligomers comprising a first amplification oligomer and a second amplification oligomer, wherein

the first amplification oligomer comprises a target hybridizing sequence consisting of the nucleotide sequence of SEQ ID NO: 30, and

the second amplification oligomer comprises a target hybridizing sequence consisting of the nucleotide sequence of SEQ ID NO: 31, and the pair of amplification oligomers amplify the stx1 gene at a concentration as low as 5.08 copies per microliter;

b) amplifying nucleic acid in the sample with the pair of amplification oligomers to obtain an amplification product; and

c) determining the sequence of the amplification product or detecting the amplification product using a detection probe oligomer comprising a fluorescent dye compound, wherein the detection probe oligomer comprises 10 to 40 contiguous nucleotides that specifically hybridize to the amplicon generated by the pair of amplification oligomers.

2. The method of claim 1 , wherein the sample comprises bacterial nucleic acid originating from Escherichia coli, Citrobacter freundii, Aeromononas hydrophila, Aeromononas caviae , or Enterobacter cloacae.

3. The method of claim 2 , wherein the detection probe oligomer further comprises a non-fluorescent quenching dye compound.

4. The method of claim 1 , wherein the detection probe oligomer comprises a length of contiguous nucleotides selected from the group consisting of: from 15 to 30 continuous nucleotides.

5. The method of claim 3 , wherein the detection probe oligomer comprises a length of contiguous nucleotides selected from the group consisting of: from 15 to 30 continuous nucleotides.

6. The method of claim 1 , wherein the sequence of the first amplification oligomer consists of SEQ ID NO: 30.

7. A method for identifying a stx1 gene in a sample, the method comprising:

a) contacting the sample with a pair of amplification oligomers comprising a first amplification oligomer and a second amplification oligomer, wherein

the sequence of the first amplification oligomer consists of SEQ ID NO: 30, and

the sequence of the second amplification oligomer consists of SEQ ID NO: 31;

b) amplifying nucleic acid in the sample with the pair of amplification oligomers to obtain an amplification product; and

c) determining the sequence of the amplification product or detecting the amplification product using a detection probe oligomer comprising a fluorescent dye compound, wherein the detection probe oligomer comprises 10 to 40 contiguous nucleotides that specifically hybridize to the amplicon generated by the pair of amplification oligomers.

8. The method of claim 1 , wherein the sequence of the second amplification oligomer consists of SEQ ID NO: 31.

9. The method of claim 7 , wherein the sequence of the detection probe oligomer consists of SEQ ID NO: 32.

10. A primer pair and a detection probe oligomer for generating from a stx1 gene an amplicon of approximately 130 bp useful for identifying the presence of a stx1 gene in a sample, the primer pair comprising a first amplification oligomer and a second amplification oligomer, wherein

the sequence of the first amplification oligomer consists of SEQ ID NO: 30, and

the sequence of the second amplification oligomer consists of SEQ ID NO:31;

the detection probe oligomer comprises 10 to 40 contiguous nucleotides that specifically hybridize to the amplicon generated by the pair of amplification oligomers, and further comprises a fluorescent dye compound.

11. A reaction mixture for generating and detecting from a stx1 gene an amplicon of approximately 130 bp useful for identifying the presence of a stx1 gene in a sample, wherein the reaction mixture comprises a first amplification oligomer, a second amplification oligomer and a detection probe oligomer, wherein

the sequence of the first amplification oligomer consists of SEQ ID NO: 30,

the sequence of the second amplification oligomer consists of SEQ ID NO: 31;

the detection probe oligomer comprises 10 to 40 contiguous nucleotides that specifically hybridize to the amplicon generated by the pair of amplification oligomers, and further comprises a fluorescent dye compound.

12. The reaction mixture of claim 11 , wherein the sequence of the detection probe oligomer consists of SEQ ID NO: 32.

Assignments (7)
RELEASE OF SECURITY INTEREST Recorded Apr 28, 2026
From: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
To: HOLOGIC, INC., ON ITS OWN BEHALF AND AS SUCCESSOR-BY-MERGER TO DIRECT RADIOGRAPHY CORP.; CYTYC CORPORATION, ON ITS OWN BEHALF AND AS SUCCESSOR-BY-MERGER TO BIOLUCENT, LLC; CYTYC SURGICAL PRODUCTS, LLC, AS SUCCESSOR-BY-CONVERSION TO CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; GEN-PROBE INCORPORATED, ON ITS OWN BEHALF AND AS SUCCESSOR-BY-MERGER TO THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE PRODESSE, INC.; SUROS SURGICAL SYSTEMS, INC.
Reel/Frame 075566/0039 →
SECURITY INTEREST Recorded Apr 8, 2026
From: BIOTHERANOSTICS, INC.; GEN-PROBE INCORPORATED; GEN-PROBE PRODESSE, INC.; CYTYC CORPORATION; SUROS SURGICAL SYSTEMS, INC.; GYNESONICS, INC.; BOLDER SURGICAL, LLC; FAXITRON BIOPTICS, LLC; HEALTH BEACONS, INC.; HOLOGIC, INC.
To: ROYAL BANK OF CANADA, AS COLLATERAL AGENT
Reel/Frame 075462/0440 →
SECURITY INTEREST Recorded Oct 12, 2021
From: HOLOGIC, INC.; FAXITRON BIOPTICS, LLC; BIOTHERANOSTICS, INC.; GEN-PROBE INCORPORATED; GEN-PROBE PRODESSE, INC.
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 057787/0526 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 14, 2018
From: TYLER, EJAN
To: GEN-PROBE PRODESSE, INC.
Reel/Frame 046798/0637 →
SECURITY AGREEMENT Recorded Aug 7, 2015
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; DIRECT RADIOGRAPHY CORP.; GEN-PROBE INCORPORATED; GEN-PROBE PRODESSE, INC.; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 036307/0199 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 11, 2015
From: TYLER, EJAN
To: GEN-PROBE PRODESSE, INC.
Reel/Frame 035825/0685 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 11, 2015
From: TYLER, EJAN
To: GEN-PROBE PRODESSE, INC.
Reel/Frame 035825/0651 →